.svg){kind=small}
Where to Buy
Flamer is stocked at 84 licensed dispensaries across New York, with the deepest coverage in New York, Flushing, Astoria, Bedford-Stuyvesant, and Bushwick. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Flamer’s mix in July 2026 was concentrated in Pre-Roll at 82.22% share while Flower held 17.78% share, with Pre-Roll down 12.93% year over year and 0.88% month over month as Flower surged 703.04% year over year despite a 1.29% month-over-month dip. Average price fell 5.41% year over year to $29.95, with Pre-Roll pricing at $28.15 and Flower at $42.58, and the brand’s overall sales grew 3.47% year over year even as Pre-Roll contracted. In New York Pre-Roll, the brand sat at rank 40, and with Pre-Roll share still above 80% alongside negative category momentum, the pattern implies that Flamer is relying on a shrinking core while using Flower’s triple-digit growth to keep headline sales positive.
The swing toward Flower—up 703.04% year over year while still only 17.78% of mix—paired with a 12.93% Pre-Roll decline and a 5.41% drop in average price indicates a value-tilt that defends unit velocity at the expense of price realization. With Pre-Roll down 0.88% month over month and Flower down 1.29% month over month, and rank 40 within New York Pre-Roll, the directional signal is that Flamer’s positioning is anchored in a lower-priced Pre-Roll portfolio that is losing rank headroom, while the expanding yet higher-priced Flower line provides mix diversification rather than immediate share recovery.
Competitive Landscape
Flamer sits at rank #40 in NY Pre-Roll for July 2026, down 14 positions year over year from #26, while improving 8 ranks versus April 2026 when it was #48, indicating a recent quarter-on-quarter climb after a longer slide; meanwhile, Ruby Farms held #1 with an 8.6% YoY sales increase and Anthem jumped from #39 to #2 with an 877.2% YoY sales surge, a contrast to Flamer’s drop from a peak of #15 in August 2024 and current #40 that implies brand relevance is concentrated in short bursts and requires repositioning toward consistent share retention.
Notable Products
Silly Goofy Pre-Roll (0.75g) posted the standout movement in July 2026 with an 86.8% MoM surge to rank 1, while Lobotomy Pre-Roll (0.75g) slipped 17.3% to rank 5. The concentration is clear: eight of the top ten are Pre-Roll SKUs, with Silly Goofy Pre-Roll 5-Pack (2.5g) dropping 37.1% at rank 2 even as the single format gained share, implying a trade-down from multipacks to singles within the same brand. With Sasha Colby Kush Infused Pre-Roll 5-Pack (2.5g) up 49.0% at rank 4 versus the non-pack variant down 41.9% at rank 9 and P.N.C Pre-Roll 5-Pack (2.5g) down 10.5% at rank 7, format polarization is shaping the lineup more than strain preference, pointing Flamer toward optimizing pack-size pricing tiers rather than launching additional strains in July 2026.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
